Cargando…

Central Diabetes Insipidus in Refractory Antineutrophil Cytoplasmic Antibody-associated Vasculitis

We herein describe two cases of refractory antineutrophil cytoplasmic antibody-associated vasculitis (AAV) complicated with diabetes insipidus (DI) possibly related to hypertrophic pachymeningitis (HP). One patient had microscopic polyangiitis and HP, which were refractory to cyclophosphamide, azath...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohashi, Keiji, Morishita, Michiko, Watanabe, Haruki, Sada, Ken-Ei, Katsuyama, Takayuki, Miyawaki, Yoshia, Katsuyama, Eri, Narazaki, Mariko, Tatebe, Noriko, Watanabe, Katsue, Kawabata, Tomoko, Wada, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709644/
https://www.ncbi.nlm.nih.gov/pubmed/28943556
http://dx.doi.org/10.2169/internalmedicine.8683-16
_version_ 1783282819067281408
author Ohashi, Keiji
Morishita, Michiko
Watanabe, Haruki
Sada, Ken-Ei
Katsuyama, Takayuki
Miyawaki, Yoshia
Katsuyama, Eri
Narazaki, Mariko
Tatebe, Noriko
Watanabe, Katsue
Kawabata, Tomoko
Wada, Jun
author_facet Ohashi, Keiji
Morishita, Michiko
Watanabe, Haruki
Sada, Ken-Ei
Katsuyama, Takayuki
Miyawaki, Yoshia
Katsuyama, Eri
Narazaki, Mariko
Tatebe, Noriko
Watanabe, Katsue
Kawabata, Tomoko
Wada, Jun
author_sort Ohashi, Keiji
collection PubMed
description We herein describe two cases of refractory antineutrophil cytoplasmic antibody-associated vasculitis (AAV) complicated with diabetes insipidus (DI) possibly related to hypertrophic pachymeningitis (HP). One patient had microscopic polyangiitis and HP, which were refractory to cyclophosphamide, azathioprine, rituximab, mycophenolate mofetil (MMF), and mizoribine. Remission was finally achieved with the use of etanercept, but DI occurred 5 years later. The other patient had granulomatosis with polyangiitis, which that was refractory to cyclophosphamide, methotrexate, MMF, and rituximab. DI subsequently developed, but was successfully treated with etanercept. Dura mater hypertrophy was macroscopically observed in the latter case.
format Online
Article
Text
id pubmed-5709644
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-57096442017-12-04 Central Diabetes Insipidus in Refractory Antineutrophil Cytoplasmic Antibody-associated Vasculitis Ohashi, Keiji Morishita, Michiko Watanabe, Haruki Sada, Ken-Ei Katsuyama, Takayuki Miyawaki, Yoshia Katsuyama, Eri Narazaki, Mariko Tatebe, Noriko Watanabe, Katsue Kawabata, Tomoko Wada, Jun Intern Med Case Report We herein describe two cases of refractory antineutrophil cytoplasmic antibody-associated vasculitis (AAV) complicated with diabetes insipidus (DI) possibly related to hypertrophic pachymeningitis (HP). One patient had microscopic polyangiitis and HP, which were refractory to cyclophosphamide, azathioprine, rituximab, mycophenolate mofetil (MMF), and mizoribine. Remission was finally achieved with the use of etanercept, but DI occurred 5 years later. The other patient had granulomatosis with polyangiitis, which that was refractory to cyclophosphamide, methotrexate, MMF, and rituximab. DI subsequently developed, but was successfully treated with etanercept. Dura mater hypertrophy was macroscopically observed in the latter case. The Japanese Society of Internal Medicine 2017-09-25 2017-11-01 /pmc/articles/PMC5709644/ /pubmed/28943556 http://dx.doi.org/10.2169/internalmedicine.8683-16 Text en Copyright © 2017 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Ohashi, Keiji
Morishita, Michiko
Watanabe, Haruki
Sada, Ken-Ei
Katsuyama, Takayuki
Miyawaki, Yoshia
Katsuyama, Eri
Narazaki, Mariko
Tatebe, Noriko
Watanabe, Katsue
Kawabata, Tomoko
Wada, Jun
Central Diabetes Insipidus in Refractory Antineutrophil Cytoplasmic Antibody-associated Vasculitis
title Central Diabetes Insipidus in Refractory Antineutrophil Cytoplasmic Antibody-associated Vasculitis
title_full Central Diabetes Insipidus in Refractory Antineutrophil Cytoplasmic Antibody-associated Vasculitis
title_fullStr Central Diabetes Insipidus in Refractory Antineutrophil Cytoplasmic Antibody-associated Vasculitis
title_full_unstemmed Central Diabetes Insipidus in Refractory Antineutrophil Cytoplasmic Antibody-associated Vasculitis
title_short Central Diabetes Insipidus in Refractory Antineutrophil Cytoplasmic Antibody-associated Vasculitis
title_sort central diabetes insipidus in refractory antineutrophil cytoplasmic antibody-associated vasculitis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709644/
https://www.ncbi.nlm.nih.gov/pubmed/28943556
http://dx.doi.org/10.2169/internalmedicine.8683-16
work_keys_str_mv AT ohashikeiji centraldiabetesinsipidusinrefractoryantineutrophilcytoplasmicantibodyassociatedvasculitis
AT morishitamichiko centraldiabetesinsipidusinrefractoryantineutrophilcytoplasmicantibodyassociatedvasculitis
AT watanabeharuki centraldiabetesinsipidusinrefractoryantineutrophilcytoplasmicantibodyassociatedvasculitis
AT sadakenei centraldiabetesinsipidusinrefractoryantineutrophilcytoplasmicantibodyassociatedvasculitis
AT katsuyamatakayuki centraldiabetesinsipidusinrefractoryantineutrophilcytoplasmicantibodyassociatedvasculitis
AT miyawakiyoshia centraldiabetesinsipidusinrefractoryantineutrophilcytoplasmicantibodyassociatedvasculitis
AT katsuyamaeri centraldiabetesinsipidusinrefractoryantineutrophilcytoplasmicantibodyassociatedvasculitis
AT narazakimariko centraldiabetesinsipidusinrefractoryantineutrophilcytoplasmicantibodyassociatedvasculitis
AT tatebenoriko centraldiabetesinsipidusinrefractoryantineutrophilcytoplasmicantibodyassociatedvasculitis
AT watanabekatsue centraldiabetesinsipidusinrefractoryantineutrophilcytoplasmicantibodyassociatedvasculitis
AT kawabatatomoko centraldiabetesinsipidusinrefractoryantineutrophilcytoplasmicantibodyassociatedvasculitis
AT wadajun centraldiabetesinsipidusinrefractoryantineutrophilcytoplasmicantibodyassociatedvasculitis